abstract |
The present invention provides an injectable formulation comprising Palonosetron hydrochloride in an aqueous medium at a concentration from 0.03 to 0.2 mg/mL and a pH from 4.0 to 6.0 contained in a single-unit dose vial for the treatment of emesis. |